Matches in Wikidata for { <http://www.wikidata.org/entity/Q58599421> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q58599421 description "artículu científicu espublizáu en payares de 2018" @default.
- Q58599421 description "im November 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q58599421 description "scientific article published on 07 November 2018" @default.
- Q58599421 description "wetenschappelijk artikel" @default.
- Q58599421 description "наукова стаття, опублікована в листопаді 2018" @default.
- Q58599421 name "Severe B cell-mediated disease activation despite two cycles of alemtuzumab in a patient with multiple sclerosis" @default.
- Q58599421 name "Severe B cell-mediated disease activation despite two cycles of alemtuzumab in a patient with multiple sclerosis" @default.
- Q58599421 type Item @default.
- Q58599421 label "Severe B cell-mediated disease activation despite two cycles of alemtuzumab in a patient with multiple sclerosis" @default.
- Q58599421 label "Severe B cell-mediated disease activation despite two cycles of alemtuzumab in a patient with multiple sclerosis" @default.
- Q58599421 prefLabel "Severe B cell-mediated disease activation despite two cycles of alemtuzumab in a patient with multiple sclerosis" @default.
- Q58599421 prefLabel "Severe B cell-mediated disease activation despite two cycles of alemtuzumab in a patient with multiple sclerosis" @default.
- Q58599421 P1433 Q58599421-5F0CA90F-088F-4F23-8DBD-AED714746151 @default.
- Q58599421 P1476 Q58599421-A511D2D7-4262-4673-956A-13E52415A784 @default.
- Q58599421 P2093 Q58599421-1170DE93-AAE1-4ABB-8279-FD755F1C6231 @default.
- Q58599421 P2093 Q58599421-7E2797CD-C1FC-4401-BAA8-2305D8D7823E @default.
- Q58599421 P2093 Q58599421-B72FF107-15B8-416E-8A5E-7B98B164CA82 @default.
- Q58599421 P2093 Q58599421-B9CA51FD-D6F7-48FC-BC16-14ACC0BB5EAD @default.
- Q58599421 P2093 Q58599421-EEFF8242-87B3-4CC6-8228-DE8CBB73B257 @default.
- Q58599421 P304 Q58599421-A7346BD9-D820-42A8-857A-24B9ED82AB79 @default.
- Q58599421 P31 Q58599421-FA254DC3-4DEF-420D-B1F0-AF59D23E68E4 @default.
- Q58599421 P356 Q58599421-404A7DCE-D054-4589-BCE7-7F62829DD360 @default.
- Q58599421 P407 Q58599421-96B70694-4D65-47B8-BA7C-99319AE7095D @default.
- Q58599421 P433 Q58599421-DF5B12F6-29B6-452C-8BF9-65A2C20D8164 @default.
- Q58599421 P478 Q58599421-016E76F2-245D-47B3-9FAF-4B3C928A648F @default.
- Q58599421 P577 Q58599421-9DCF9A29-8BEF-4C8B-BB2A-5A962001C74C @default.
- Q58599421 P698 Q58599421-0A84A1E9-35EB-4058-B2B7-A01CADBFB141 @default.
- Q58599421 P921 Q58599421-C702AE96-7778-4CCC-8DA5-267EE746EDFF @default.
- Q58599421 P356 1352458518810261 @default.
- Q58599421 P698 30403365 @default.
- Q58599421 P1433 Q1952449 @default.
- Q58599421 P1476 "Severe B cell-mediated disease activation despite two cycles of alemtuzumab in a patient with multiple sclerosis" @default.
- Q58599421 P2093 "Gayoung Kim" @default.
- Q58599421 P2093 "Ho Jin Kim" @default.
- Q58599421 P2093 "Jae-Won Hyun" @default.
- Q58599421 P2093 "Su-Hyun Kim" @default.
- Q58599421 P2093 "Yeseul Kim" @default.
- Q58599421 P304 "1942-1945" @default.
- Q58599421 P31 Q13442814 @default.
- Q58599421 P356 "10.1177/1352458518810261" @default.
- Q58599421 P407 Q1860 @default.
- Q58599421 P433 "14" @default.
- Q58599421 P478 "25" @default.
- Q58599421 P577 "2018-11-07T00:00:00Z" @default.
- Q58599421 P698 "30403365" @default.
- Q58599421 P921 Q8277 @default.